All sizes of pharmaceutical firms from giants like Johnson & Johnson to young guns like Moderna, yet to bring their…
McAlinden Research PartnersApril 1, 2020
The FDA and a number of major pharmaceutical firms have warned of drug shortages resulting from chemical plant shut downs…
McAlinden Research PartnersMarch 3, 2020
The coronavirus outbreak aka 2019-nCoV is having an outsize impact on some industries and their share prices. Airline, energy, and…
McAlinden Research PartnersFebruary 3, 2020
A virus called 2019-nCoV that emerged last month in Central China is spreading so fast that it risks becoming a…
McAlinden Research PartnersJanuary 23, 2020
New research on CRISPR techniques that could provide treatments and improved diagnostics for several major viruses and other medical conditions…
McAlinden Research PartnersNovember 13, 2019
New developments in CRISPR gene editing technology have opened the door to potential cures for 89% of known disease-causing genetic…
McAlinden Research PartnersOctober 29, 2019
As the massive 2700-case litigation against major producers and distributors of opioids continues in Ohio, many lawyers and Attorneys General…
McAlinden Research PartnersOctober 23, 2019
The prevalence of chronic diseases combined with their sky-high price tags is drawing interest to digital therapeutics (DTx), a new…
McAlinden Research PartnersOctober 21, 2019
In two back-to-back blockbuster headlines, Johnson & Johnson was found liable for damages related to the US opioid crisis and…
McAlinden Research PartnersAugust 28, 2019
